Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2017129699) IMMUNOPROPHYLAXIS FOR RECURRENT BACTERIAL INFECTIONS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2017/129699 International Application No.: PCT/EP2017/051683
Publication Date: 03.08.2017 International Filing Date: 26.01.2017
IPC:
A61K 31/721 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
715
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
716
Glucans
721
Dextrans
Applicants:
STRATHMANN GMBH & CO. KG [DE/DE]; Sellhopsweg 1 22459 Hamburg, DE
Inventors:
BEHNKE, Bert; DE
PESCHEL, Claudia; DE
Agent:
HAMM&WITTKOPP PATENTANWÄLTE; Jungfernstieg 38 20354 Hamburg, DE
Priority Data:
10 2016 101 448.627.01.2016DE
Title (DE) IMMUNPROPHYLAXE BEI REZIDIVIERENDEN BAKTERIELLEN INFEKTIONEN
(EN) IMMUNOPROPHYLAXIS FOR RECURRENT BACTERIAL INFECTIONS
(FR) PROPHYLAXIE IMMUNITAIRE POUR DES INFECTIONS BACTÉRIENNES RÉCIDIVANTES
Abstract:
(DE) Die vorliegende Erfindung betrifft die Verwendung von Dextran als Impfstoff, insbesondere zur prophylaktischen Behandlung von rezidivierenden Infektionen bakterieller Herkunft. Außerdem betrifft die vorliegende Erfindung eine Impfstoffzusammensetzung, die Dextran als einzigen Impfstoff und ein Adjuvans, vorzugsweise eine Aluminiumverbindung, enthält sowie einen Arzneimittel-Kit zur Herstellung der Impfstoffzusammensetzung.
(EN) The invention relates to the use of dextran as a vaccine, in particular for the prophylactic treatment of recurrent infections of bacterial origin. The invention also relates to a vaccine composition containing dextran as a single vaccine and an adjuvant, preferably an aluminium compound, and to a medicament kit for producing the vaccine composition.
(FR) La présente invention concerne l'utilisation de dextran comme vaccin, notamment pour le traitement prophylactique d'infections récidivantes d’origine bactérienne. L'invention concerne également une composition vaccinale contenant du dextran comme vaccin unique et un adjuvant, de préférence un composé aluminium; et une trousse de médicaments pour préparer ladite composition vaccinale.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: German (DE)
Filing Language: German (DE)
Also published as:
EP3407899